BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12902311)

  • 1. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula.
    Nestor PJ; Graham NL; Fryer TD; Williams GB; Patterson K; Hodges JR
    Brain; 2003 Nov; 126(Pt 11):2406-18. PubMed ID: 12902311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia.
    Mandelli ML; Vilaplana E; Brown JA; Hubbard HI; Binney RJ; Attygalle S; Santos-Santos MA; Miller ZA; Pakvasa M; Henry ML; Rosen HJ; Henry RG; Rabinovici GD; Miller BL; Seeley WW; Gorno-Tempini ML
    Brain; 2016 Oct; 139(Pt 10):2778-2791. PubMed ID: 27497488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two insular regions are differentially involved in behavioral variant FTD and nonfluent/agrammatic variant PPA.
    Mandelli ML; Vitali P; Santos M; Henry M; Gola K; Rosenberg L; Dronkers N; Miller B; Seeley WW; Gorno-Tempini ML
    Cortex; 2016 Jan; 74():149-57. PubMed ID: 26673947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
    Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
    Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Damage to the anterior arcuate fasciculus predicts non-fluent speech production in aphasia.
    Fridriksson J; Guo D; Fillmore P; Holland A; Rorden C
    Brain; 2013 Nov; 136(Pt 11):3451-60. PubMed ID: 24131592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognition and anatomy in three variants of primary progressive aphasia.
    Gorno-Tempini ML; Dronkers NF; Rankin KP; Ogar JM; Phengrasamy L; Rosen HJ; Johnson JK; Weiner MW; Miller BL
    Ann Neurol; 2004 Mar; 55(3):335-46. PubMed ID: 14991811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
    Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
    J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia.
    Turner RS; Kenyon LC; Trojanowski JQ; Gonatas N; Grossman M
    Ann Neurol; 1996 Feb; 39(2):166-73. PubMed ID: 8967747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging in a case of the semantic variant of primary progressive aphasia.
    Küper M; Zöller M; Liebeskind S; Wiltfang J; Benninghoff J
    Fortschr Neurol Psychiatr; 2013 Jul; 81(7):e14-6. PubMed ID: 23856947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation.
    Teichmann M; Kas A; Boutet C; Ferrieux S; Nogues M; Samri D; Rogan C; Dormont D; Dubois B; Migliaccio R
    Brain; 2013 Nov; 136(Pt 11):3474-88. PubMed ID: 24108322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography.
    Zahn R; Buechert M; Overmans J; Talazko J; Specht K; Ko CW; Thiel T; Kaufmann R; Dykierek P; Juengling F; Hüll M
    Psychiatry Res; 2005 Nov; 140(2):115-31. PubMed ID: 16253483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of word-meaning with spared object semantics in a case of mixed primary progressive aphasia.
    Knels C; Danek A
    Brain Lang; 2010 May; 113(2):96-100. PubMed ID: 20034661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical types of FTLD: progressive nonfluent aphasia; comparative discussions on the associated clinical presentations].
    Fukui T
    Brain Nerve; 2009 Nov; 61(11):1252-8. PubMed ID: 19938681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connected speech production in three variants of primary progressive aphasia.
    Wilson SM; Henry ML; Besbris M; Ogar JM; Dronkers NF; Jarrold W; Miller BL; Gorno-Tempini ML
    Brain; 2010 Jul; 133(Pt 7):2069-88. PubMed ID: 20542982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive nonfluent aphasia and its characteristic motor speech deficits.
    Ogar JM; Dronkers NF; Brambati SM; Miller BL; Gorno-Tempini ML
    Alzheimer Dis Assoc Disord; 2007; 21(4):S23-30. PubMed ID: 18090419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of primary progressive aphasia. A 14-year follow-up study with neuropathological findings.
    Schwarz M; De Bleser R; Poeck K; Weis J
    Brain; 1998 Jan; 121 ( Pt 1)():115-26. PubMed ID: 9549492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical atrophy and language network reorganization associated with a novel progranulin mutation.
    Cruchaga C; Fernández-Seara MA; Seijo-Martínez M; Samaranch L; Lorenzo E; Hinrichs A; Irigoyen J; Maestro C; Prieto E; Martí-Climent JM; Arbizu J; Pastor MA; Pastor P
    Cereb Cortex; 2009 Aug; 19(8):1751-60. PubMed ID: 19020205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.